Skip to main content

Andreea has a background in Life Science and Chemistry, with a focus on applications of core science into medical devices.

At Oxentia, Andreea supports corporate clients, and clients in the higher education sector. Before joining Oxentia in 2021, Andreea was a Development Scientist at Oxford Nanopore Technologies, where she worked on developing a sequencing-based COVID-19 diagnostic kit. Andreea has a MSc degree in Pharmacology from the University of Oxford and graduated from her BSc degree in Medicinal Chemistry from UCL with the Parke-Davis Prize.

Outside of Oxentia, Andreea is a tea enthusiast, tennis player and enjoys reading about the latest breakthroughs in biotechnology.


  • Innovation Management Consultancy, corporate and academic
  • Development of sequencing technology into medical devices
  • Life Science and Pharmaceuticals – Drug targets and Drug Discovery pipelines


  • M.Sc. (Distinction) in Pharmacology, University of Oxford, 2020
  • B.Sc. (1:1) in Medicinal Chemistry, University College London, 2019
Connect on LinkedIn

Contact Me

This website site uses cookies to improve your browsing experience. By continuing to use this site, you are agreeing to our use of cookies. Review our privacy policy.

Accept and close